Cargando…

Pyruvate kinase M2 is a poor prognostic marker of and a therapeutic target in ovarian cancer

Pyruvate kinase M2 (PKM2) regulates glycolysis and oxidative phosphorylation; however, the role of PKM2 in ovarian cancer remains largely unknown. We investigated whether ovarian cancer metabolism could provide insight into the development of therapeutic strategies. We performed immunohistochemical...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chao, Tai-Kuang, Huang, Tien-Shuo, Liao, Yu-Ping, Huang, Rui-Lan, Su, Po-Hsuan, Shen, Hueng-Yuan, Lai, Hung-Cheng, Wang, Yu-Chi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5533430/ https://www.ncbi.nlm.nih.gov/pubmed/28753677 http://dx.doi.org/10.1371/journal.pone.0182166

Ejemplares similares

Pyruvate Kinase M2 Expression: A Potential Metabolic Biomarker to Differentiate Endometrial Precancer and Cancer that is Associated with Poor Outcomes in Endometrial Carcinoma
por: Lai, Yu-Ju, et al.
Publicado: (2019)

Overexpression of Pyruvate Dehydrogenase Kinase-3 Predicts Poor Prognosis in Urothelial Carcinoma
por: Kuo, Yu-Hsuan, et al.
Publicado: (2021)

Preclinical evaluation of a nanoformulated antihelminthic, niclosamide, in ovarian cancer
por: Lin, Chi-Kang, et al.
Publicado: (2016)

An epigenetic signature of adhesion molecules predicts poor prognosis of ovarian cancer patients
por: Chang, Ping-Ying, et al.
Publicado: (2017)

Ovarian cancer stem-like cells with induced translineage-differentiation capacity and are suppressed by alkaline phosphatase inhibitor
por: Liu, Kuei-Chun, et al.
Publicado: (2013)

Pyruvate kinase M2 is a marker of poor prognosis in lung adenocarcinoma but not lung squamous cell carcinoma
por: Zhang, Junxia, et al.
Publicado: (2020)

Epigenomic Profiling of Epithelial Ovarian Cancer Stem-Cell Differentiation Reveals GPD1 Associated Immune Suppressive Microenvironment and Poor Prognosis
por: Chen, Lin-Yu, et al.
Publicado: (2022)

Hypermethylation of the TGF-β target, ABCA1 is associated with poor prognosis in ovarian cancer patients
por: Chou, Jian-Liang, et al.
Publicado: (2015)

Isoform Switch of Pyruvate Kinase M1 Indeed Occurs but Not to Pyruvate Kinase M2 in Human Tumorigenesis
por: Zhan, Cheng, et al.
Publicado: (2015)

Protein kinase function of pyruvate kinase M2 and cancer
por: Chen, Xun, et al.
Publicado: (2020)

Role of isoenzyme M2 of pyruvate kinase in urothelial tumorigenesis
por: Zhou, Haiping, et al.
Publicado: (2016)

Psychometric validation of the Pyruvate Kinase Deficiency Diary and Pyruvate Kinase Deficiency Impact Assessment in adults in the phase 3 ACTIVATE trial
por: Andrae, David A., et al.
Publicado: (2023)

Ovarian cancer detection by DNA methylation in cervical scrapings
por: Wu, Tzu-I, et al.
Publicado: (2019)

SH2 domain-containing phosphatase 1 regulates pyruvate kinase M2 in hepatocellular carcinoma
por: Tai, Wei-Tien, et al.
Publicado: (2016)

Development of the pyruvate kinase deficiency diary and pyruvate kinase deficiency impact assessment: Disease‐specific assessments
por: Salek, Sam, et al.
Publicado: (2020)

Paired Box-1 (PAX1) Activates Multiple Phosphatases and Inhibits Kinase Cascades in Cervical Cancer
por: Su, Po-Hsuan, et al.
Publicado: (2019)

Transcriptional Regulation of Pyruvate Dehydrogenase Kinase
por: Jeong, Ji Yun, et al.
Publicado: (2012)

An engineered photoswitchable mammalian pyruvate kinase
por: Gehrig, Stefanie, et al.
Publicado: (2017)

Molecular heterogeneity of pyruvate kinase deficiency
por: Bianchi, Paola, et al.
Publicado: (2020)

Pyruvate Kinase, Inflammation and Periodontal Disease
por: Grant, Melissa M.
Publicado: (2021)

Pyruvate Kinase Deficiency Causing Priapism
por: Shankar, Vinay Hanyalu, et al.
Publicado: (2023)

Pyruvate Kinase M2 and Lactate Dehydrogenase A Are Overexpressed in Pancreatic Cancer and Correlate with Poor Outcome
por: Mohammad, Goran Hamid, et al.
Publicado: (2016)

Upregulated expression of pyruvate kinase M2 mRNA predicts poor prognosis in lung adenocarcinoma
por: Wang, Guiping, et al.
Publicado: (2020)

iNOS-derived nitric oxide promotes glycolysis by inducing pyruvate kinase M2 nuclear translocation in ovarian cancer
por: Li, Linlin, et al.
Publicado: (2017)

HSP40 Interacts with Pyruvate Kinase M2 and Regulates Glycolysis and Cell Proliferation in Tumor Cells
por: Huang, Liangqian, et al.
Publicado: (2014)

Kinetic Characterization and Inhibitor Screening of Pyruvate Kinase I From Babesia microti
por: An, Xiaomeng, et al.
Publicado: (2021)

Faecal tumour pyruvate kinase M2: not a good marker for the detection of colorectal adenomas
por: Shastri, Y M, et al.
Publicado: (2008)

Plasma Pyruvate Kinase M2 as a marker of vascular inflammation in giant cell arteritis
por: Esen, Idil, et al.
Publicado: (2021)

Cysteine catabolism and the serine biosynthesis pathway support pyruvate production during pyruvate kinase knockdown in pancreatic cancer cells
por: Yu, Lei, et al.
Publicado: (2019)

Pyruvate Dehydrogenase Kinase 4 Promotes Vascular Calcification via SMAD1/5/8 Phosphorylation
por: Lee, Sun Joo, et al.
Publicado: (2015)

Crystal Structure of Cryptosporidium parvum Pyruvate Kinase
por: Cook, William J., et al.
Publicado: (2012)

The Role of Pyruvate Dehydrogenase Kinase in Diabetes and Obesity
por: Lee, In-Kyu
Publicado: (2014)

Comorbidities and complications in adults with pyruvate kinase deficiency
por: Boscoe, Audra N., et al.
Publicado: (2021)

Methylomic Analysis Identifies Frequent DNA Methylation of Zinc Finger Protein 582 (ZNF582) in Cervical Neoplasms
por: Huang, Rui-Lan, et al.
Publicado: (2012)

Dichloroacetate and Pyruvate Metabolism: Pyruvate Dehydrogenase Kinases as Targets Worth Investigating for Effective Therapy of Toxoplasmosis
por: Ferrarini, Mariana Galvão, et al.
Publicado: (2021)

Pyruvate Kinase M2 Expression, but Not Pyruvate Kinase Activity, Is Up-Regulated in a Grade-Specific Manner in Human Glioma
por: Mukherjee, Joydeep, et al.
Publicado: (2013)

Computational Study on New Natural Compound Inhibitors of Pyruvate Dehydrogenase Kinases
por: Zhou, Xiaoli, et al.
Publicado: (2016)

Interaction with Pyruvate Kinase M2 Destabilizes Tristetraprolin by Proteasome Degradation and Regulates Cell Proliferation in Breast Cancer
por: Huang, Liangqian, et al.
Publicado: (2016)

ARNT deficiency represses pyruvate dehydrogenase kinase 1 to trigger ROS production and melanoma metastasis
por: Huang, Chi-Ruei, et al.
Publicado: (2021)

Overexpression of PLOD3 promotes tumor progression and poor prognosis in gliomas
por: Tsai, Chia-Kuang, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_rbaupbunthfbgl2orgo2u2ssm8